Astrana Health, Inc. reported a material weakness in internal control
Internal control reported effective→Material weakness in internal control
The following material weakness has been identified and included in management’s assessment. Management has identified a material weakness in the design of the Company’s internal control over financial reporting related to accounting for business combinations. Specifically, the Company did not design and implement effective controls to ensure the completeness and accuracy of the determination of net working capital acquired, including the identification and valuation of current assets and current liabilities as of…
Evidence
Current state
material_weakness
Current state label
Material weakness in internal control
Direction
newly reported
Prior filed
2025-03-14
Prior form
10-K
Prior state
effective
Prior state label
Internal control reported effective
Remediation stated
Yes
Severity
high
Source
Item 9A internal control conclusion, compared with the prior filing
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.
Astrana Health, Inc. told the SEC it could not file its annual report on time
(the “Company”) is unable to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”) within the prescribed time period without unreasonable effort or expense. The 2025 Form 10-K cannot be filed by the prescribed due date because additional time, resources and effort are required to complete work related to the Company’s financial reporting and close procedures, specifically as a result of the Company’s acquisition of certain entities. In connection with the filing of the 2025 Form 10-K, when made, the Company anticipates reporting a material weakness in the Company’s internal control over financial reporting, which is expected to relate…
Evidence
Days past due date
-29
Routine
No
Severity
high
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”) within the prescribed time period without unreasonable effort or expense. The 2025 Form 10-K cannot be filed by the prescribed due date because additional time, resources and effort are required to complete work related to the Company’s financial reporting and close procedures, specifically as a result of the Company’s acquisition of certain entities. In connection with the filing of the 2025 Form 10-K, when made, the Company anticipates reporting a material weakness in the Company’s internal control over financial reporting, which is expected to relate…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.